ESC Professional Premium Access

Coronary artery disease - Epidemiology, prognosis, outcome 4

Event: ESC Congress 2022
Topic: Epidemiology, Prognosis, Outcome
Session type: Moderated ePosters
Date: 28 August 2022
Time: 09:15 - 09:55

Congress Session

6 presentations in this session

Outcomes following acute myocardial injury and type 2 myocardial infarction in patients with and without coronary artery disease

Speaker: Doctor C. Taggart (Edinburgh, GB)
Thumbnail

Atrial fibrillation in patients with high-risk acute myocardial infarction - The PARADISE-MI Trial

Speaker: Associate Professor M. Cikes (Zagreb, HR)
Thumbnail

Infarction of the papillary muscle is an independent predictor of heart failure, ventricular tachycardia, and consequent mortality

Speaker: Mr C. Beijnink (Nijmegen, NL)
Thumbnail

Acute myocardial infarction and work inability: Insights from the AMIS Plus registry

Speaker: Professor H. Rickli (St. Gallen, CH)
Thumbnail

Very long-term outcomes after acute myocardial infarction in young men and women

Speaker: Doctor O. Weizman (Boulogne Billancourt, FR)
Thumbnail

A UK retrospective analysis of recurrent cardiovascular events following acute myocardial infarction in patients with multivessel disease and additional risk factors

Speaker: Ms R. Mcclintock (London, GB)
Thumbnail

6 speakers from this session

Doctor Caelan Taggart

University of Edinburgh, Edinburgh (United Kingdom of Great Britain & Northern Ireland)
0 follower

Associate Professor Maja Cikes

University Hospital Centre Zagreb, Zagreb (Croatia)
24 presentations
4 followers

Mr Casper Willem Hijman Beijnink

Radboud University Medical Centre, Nijmegen (Netherlands (The))
0 follower

Professor Hans Rickli

Cantonal Hospital St. Gallen, St. Gallen (Switzerland)
0 follower

Doctor Orianne Weizman

Ambroise Pare Aphp Site of Ouest University Hospital, Boulogne Billancourt (France)
2 presentations
0 follower

Ms Rebeka Mcclintock

, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

This platform is supported by

logo Novo Nordisk